WO2001028415A1 - Animal health diagnosis - Google Patents
Animal health diagnosis Download PDFInfo
- Publication number
- WO2001028415A1 WO2001028415A1 PCT/US2000/025924 US0025924W WO0128415A1 WO 2001028415 A1 WO2001028415 A1 WO 2001028415A1 US 0025924 W US0025924 W US 0025924W WO 0128415 A1 WO0128415 A1 WO 0128415A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- data
- animal
- genetic
- database
- remote user
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/20—Heterogeneous data integration
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/90—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to alternative medicines, e.g. homeopathy or oriental medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
- Y10S128/921—Diet management
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
- Y10S128/923—Computer assisted medical diagnostics by comparison of patient data to other data
Definitions
- the invention is concerned with animal health diagnosis More particularly the invention is dir ected to the tcsiiim diagnosis and prediction ol diseases and disoi tiers ol animal companions lor instance dons and cats
- I urther th is invention relates to a method s ⁇ stem and apparatus loi the management ol comprehensive and cumulative uenetic and health assessment databases in relation to animals worldwide
- the physical attributes and other desc ⁇ pfv ⁇ and health assessment information is general ly termed in this ⁇ application as the phenotvpic information
- Genetic disorder information is termed in this application as the genotvpic information Generally these are two distinct and differing sets of information
- the physical descriptive and health assessment profiles include characteristics such as the physiological !0 pathological endoc ⁇ nological hematological epidemiological behavioral and immunological data from parameters such as phenotvpe breed hfespan, health history and presence of infectious diseases and metabolic disorders All of this is part of the phenotypic information
- a health assessment profile ot an animal tvpicallv relates to a particular subject of the group as opposed to the group of animals as a whole Generally the phenotvpe is the genetic nature ot an organism that is revealed bv visible characteristics or measurable performance in contradistinction to the genorvpe which may not be evident without a breeding test or genetic map
- the genotvpic information relates to genetic mapping, genetic background and genetic screening databases
- gene product means the specific phenotvpic characte ⁇ st ⁇ c( s) resulting from the expression ot the genotvpe and mav include certain specific laboratory test data
- abnormal or non-normal conditions are normally the sub
- the genotypic information typically relates to individual animals or a group or class of animals and is most often stored manually in a non-CDPR facility It is not typically stored bv veterinarians in a clinical setting, since the genotypic data is a specialist form of data used mainly for cataloging and research of diseases and disorders 5 among animals It is also not generally available for access to assist in the clinical analysis diagnosis and therapeutic management of animals
- This genotvpic information namely the physical characteristics and genetic makeup (pedigree) heritable disorder history, and related health history of animals in the group is usually manually recorded bv breeders owners and researchers of companion and other valued animals
- the genetic constitution of an organism includes genes without visible effects as well as those revealed by the phenotype It may refer to all the genes or to a single pair of alleles
- the genotypic information is transmitted manually to and from persons or local and national genotypic databases maintained for specific disorders and designed to loster research into diseases and disoi dei s rather than being readilv accessible to users tor clinical purposes in the manner ot phenotvpic data on a C DPR
- Some of the genetic data are available on registries related to specific diseases or disorders, toi instance, hip dvsplasia, eve conditions thyroid conditions and blood conditions
- Such disease-specific registries ai e usually set s up either by identifying af fected animal breeds or are indexed bv disease or disorder I he genetic information databases are general ly closed (kept confidential), but in some cases mav be open to researchers or members ot groups, associations and clubs
- 10 1 o promote better health among animals which can be animal companions sport animals, farm animals, and the like, such as canine, feline equine bovine porcine, caprine, ovine, and zoo animals or wildlife it is important to secure accessible genotypic or genetic information databases It is also important to be able to relate these genotypic databases to the health assessment profiles or phenotvpic databases ot particular sub
- the phenotvpe data tor an animal include the health assessment profile breed and the physical characteristics ot the animal
- the genotype data include the genetic map, pedigree tamilv history, genetic screening tests, and disorder and disease characteristics of a particular animal, animal family, line, or group of animals 0 There is a need to develop these data in a cumulative comprehensive, and dynamic svstem of database management to thereby enhance the health predictability and longevity of animals
- phenotypic information and genotypic information it is not known to store and/or present phenotypic information and genotypic information as a comprehensive and cumulative assessment ot individual animal subjects, families of subjects, breeds of subjects, or 0 species of animals in a computerized format which is available through computer networking to authorized remote users
- Tl IT INVfNT ION I he invention is directed to a method apparatus and svstem of obtaining analvzmg and reporting laboratory test data in relation to the health assessmant data of an animal together w ith the genetic data related to that same animal
- I s I hese data include a panel ot tests related to at least one ot endocrine f unction immunologic function gastrointestinal f unction and nutritional analy sis inborn errors ol metabol ism paternity DN ⁇ fingerprinting hemostasis and coagulation function vaccinal antibody status adverse and potential adverse vaccine reaction infectious diseases pathology blood typing and bone marrow analysis cell cvtotoxicity cv tokme and allergy testing and markers ot neoplastic and paraneoplastic change
- These data are relevant to the hkelv morbidity hkelv 0 longevity and'or the potential risk for disease or disorder tor the animal
- health profiling ot an animal is effected to determine characteristics related to the temperament ot the animal which impacts on its longevity
- Biological laboratory test data from a bodily fluid or tissue ot an animal are analyzed
- Such test data relate to the level of neurotransmitter activity of the animal
- the data relate to at least one ot the value of serotonin the gamma-aminobutv ⁇ c acid (GABA) the
- the test data relates to at least one ot cell cy totoxicitv markers cvtokme and chemokine levels immunoglobulin levels tvpe and amount of lvmphocvte subsets and Ivmphocvte markers and markers ot neoplastic or paraneoplastic change of the animal
- the value should fall within predetermined levels as a determinant of the immune stimulation reaction neoplastic or paraneoplastic change, or the cellular inflammatory response
- health profiling ot an animal determines characteristics related to inherited organ dysfunction or dvsplasia of the animal at least one of which is neuronal neuromuscular or renal Biological laboratory test data from a bodilv fluid or tissue of an animal are analyzed
- the test data relate to an ammo acid carbohydrate, hpid or other metabolic component body fluid or tissue marker of the animal
- the data includes obtaining data related to at least one of the value of the methy l malonic acid the fucose- containing
- health profiling ol an animal determ ines characteristics related to autoimmune thy roiditis ol the animal Biological laboratory test data trom a bodily fluid or tissue ot an ⁇ animal are analyzed I he test data r elate to a physiologic or genetic marker lor automimmune tl roiditis ot the animal I he data relates to at least one of the results ot a comprehensive thvroid autoantibodv test profile.
- DNA fingerprint (the gene map ), and markers for immunoglobulin receptors on B-cel ls T-cel l receptors and protein products ol the ma
- PCR sequence-specific primers SSP The values should fall within predetermined levels as a determinant ol autoimmune thvroiditis
- health profiling ol an animal determines characteristics related to presence ot or susceptibiltv to mammary cancer ot the animal
- Biological laboratory test data from a bodilv fluid I s or tissue ot an animal are analv/ed t he test data relate to estrogen (estrad ⁇ ol- 1 713) estrogen receptors interleukin
- health profiling ot an animal determines characteristics related to the tissue environment ot the eve and brain ( ocular and blood-brain barrier) which are sites protected from the 0 normal lmmunologic surveillance mechanisms
- Biological laboratory test data trom a bodilv fluid or tissue of an animal are analyzed The test data relate to the soluble and cellular immune inflammatory response mediators
- health profiling of an animal determines characteristics related 5 to the tendency to bleed excessively are determined
- Biological laboratory test data from a bodily fluid or tissue ot an animal are analyzed
- the test data relate to a comprehensive assessment of the hemostatic and coagulation function The value should fall within predetermined levels as a determinant ot the presence ot bleeding disorder
- the invention includes obtaining genetic data related to the animal and relating the genetic data related to that animal with the biological data Also the profiling includes obtaining data related to the current health 0 condition of the animal
- the invention comprises combining genetic data of animals with health assessment data of animals thereby to permit an analysis predicting health disease and disorder probabilities and longevity ot selected animals
- the combination is analyzed, and a report is provided to a remote user based on the analysis the health assessment data of the animal and the genetic data 5
- a system for managing animal diagnosis including the performance of specific tests
- the phenotypic and genotypic data and information relating to animals particularly purebred animals can be used to enhance the prediction of disease and /or disorder
- the invention also provides a bioinformatics system for inputting, controlling, analyzing and outputting of a broad range of criteria related to the health, genetic background and longevity of animals
- a bioinformatics system for inputting, controlling, analyzing and outputting of a broad range of criteria related to the health, genetic background and longevity of animals
- a system for screening of genetic data and genomic mapping and integrating the phenotype health assessment data and genetic identifier and issessmcnt data in a DPR
- Moreov er there is provided a sy stem tor analyzing the health assessment or phenotvpic data with the interrelated genetic or genotvpic data I hereafter those data and analyses are communicated trom the C DPR in a br oad r ange and in a manner that has not previously been possible
- 1 he present invention oi lers a unique solution to above-described problems by providing an apparatus s method and sy stem in relation to animals lor performing data analyses of biological specimens trom specific subject animals or animal groups in relation to specific subject animal or animal groups ot genetic data
- I he apparatus method and sy stem comprises a controller toi obtaining inputting and analyzing biological physiological and pathological test data together with genomic mapping and genetic screening data into the C DPR
- I he CDPR includes at least tw o databases one of the databases contains genetic information in relation to animals and the other is a phenoty pic database
- genetic database includes data trom selected animals animal families animal breeds and/or data related to selected animal diseases and/or disorders
- Other databases include those related to genetic markers or maps of animals databases related to 0 epidemiology purebred animal ownership identification registries and studbook registries
- the phenotvpe health profile or health assessment database contains data which is mostly phenotvpic
- the genotype database includes data which is in the category ot mostly genotvpe or genetic and w hich may include a second category ot some phenotvpe data which predicts or manifests the genotype and genetic data
- the invention includes relating the phenotypic data to either one or both types ot the genotvpic data 5
- Information in the databases are used to build computer driven statistical models to predict the occurrence of specific diseases and longevity for individual animals on a breed-bv-breed or familv and group basis Multiva ⁇ ate statistical techniques are used including multiple regression logistic regression and Cox proportional hazards As new diagnostic technology and genom ic information become available the database is continually expanded and the statistical models are updated to enhance predictive ability This ability to predict the occurrence of disease or 0 disorder is used to develop and evaluate screening programs in veterinarv medicine in order to detect disease earlier thereby improving the outcome and quality of life for animals and their owners The information
- a further aspect of the invention is the accessibility ot the health assessment database and/or genetic database or other databases of the CDPR by the remote user selected on the basis of password, security control and financial 0 payment such that the data can be transmitted into and from the CDPR by a computer network
- Use of selected passwords encryption systems and payment systems are employed to facilitate and restrict the flow of data in ind/or out ot the databases
- a lerts can be set up to advise ol attempts at unauthorized access to the C DPR I he computer network mav conveniently include the Internet
- the data in the C DPR can also be distr icited to multiple authorized r emote parties namely third parties lor research or other analysis
- I he invention also includes a method and svstem tor achieving this s 1 urther aspects ot the present invention will become apparent in the cour se ot the following description and bv reterence to the attached di awings
- I igure 1 is an overall view ot a web-based svstem to provide access to a database management svstem ot an 1 animal genetic database and a health assessment database of the invention in relation to the Internet
- Figure 2 is a graphical illustration ol a computer network namelv the Internet
- F igure 3 is a block diagram of an exemplary computer svstem for practicing various aspects of the invention
- Figure 4 is a view ot a browser for the database management svstem for accessing an animal genetic database and a health assessment database of the invention
- I s Figure s is a basic flow diagram il lustrating an exemplary process bv which an operator ot a C DPR receives and transm its data relating to health assessment and genetic information
- Figure 6 is a detailed flow diagram ot the svstem steps employed in one embodiment of the present invention wherein a remote user accesses and outputs data
- F igure 7 is a detailed flow diagram of the methods and steps employed bv a remote user to add data to the 0 database
- Figure 8 is a flow chart illustrating an exemplary process bv which the laboratorv dynam ically contributes transmits and receives data associated ith health assessment and genetic data to the CDPR
- phenotvpic biochemical marker e g as measured in a blood urine or saliva test electrocardiogram sk in biopsy eve examination or hair analvsis
- Some current examples include testing for bleeding disorders like von Willebrand disease and hemophilia autoimmune thy roid disease leading to hv pothvroidism the various eve heart metabolic enzvme and storage disorders and the bone and neuromuscular diseases C oupled with this approach to elim inating undesirable traits is the necessity to evaluate breeding stock regularly lor overall soundness
- a comprehensive worldwide database contains the following information tor individual purebred animals 5 Host characteristics age sex neuter status pedigree height weight body mass index coloration and markings ev e color etc
- Medical history occurrence of diseases infections etc including date of onset treatment duration and 0 outcome cause of death and method of diagnosis tvpe and amount of medications used for treatment or prevention of disease type and trequencv of vaccinations
- Laboratory data consists of routinely collected blood serum chemistry tests u ⁇ nalvsis etc as well as laboratory tests performed to screen for or diagnose specific conditions such as immune-mediated thvroiditis 5 hv pothv roidism, cancer, etc
- Osteosarcoma The risk of osteosarcoma increases with increasing age increasing v ⁇ eight and increasing height Compared with the German shepherd breed the highest risk ot osteosarcoma occurs among large and giant breeds, while small breeds have reduced risk Furthermore the risk of osteosarcoma is increased two-fold in neutered dogs 5 GDV Factors that increase the risk of GDV in purebred dogs are male gender being underweight eating onlv one meal per day eating rapidlv and a fearful temperament Factors that decrease the risk of G DV include a happv temperament and inclusion ot table foods in the diet The lifetime risk of developing GDV in large and giant breed dogs is 20° o and 23° o respectively whereas the lifetime risk of dy ing of GDV for these breeds is 6° o
- the phenotvpe component (measurable gene product) is tvpicallv less than 20%
- One or more of a panel of tests relate to at least one ot endocrine (unction immunologic function gastrointestinal function and nutritional analysis inborn errors ot metabolism paternity DNA fingerprinting hemostasis and coagulation lunction vaccinal antibodv status adverse and potential adverse vaccine reaction infectious diseases pathology, blood typing and bone marrow analysis, cell cytotoxicity c tokines and allergy testing, and markers ot neoplastic or paraneoplastic change
- ot endocrine unction immunologic function gastrointestinal function and nutritional analysis inborn errors ot metabolism paternity DNA fingerprinting hemostasis and coagulation lunction vaccinal antibodv status adverse and potential adverse vaccine reaction infectious diseases pathology, blood typing and bone marrow analysis, cell cytotoxicity c tokines and allergy testing, and markers ot neoplastic or paraneoplastic change
- Biological laboratory test data trom a bodily fluid or tissue of an animal are analyzed Such test data relate to the level of neurotransmitter activity of the animal
- the data relate to at least one of the value of serotonin, the gamma- aminobuty ⁇ c acid (GABA), the glutamate. the dopamine the glycine. the aspartate. the acetylcholine, the norepinephrine the histamine. the substance P. the vasopressin. the vasoactive intestinal peptide. the neurotensin.
- GABA gamma- aminobuty ⁇ c acid
- neurotransmitters such as serotonin, eptnephrine. norepinephrine. glutamate, and GABA can be measured by standard immunochemical techniques involving commercially available antibodies, either polyclonal or monoclonal Such antibodies are commercially available from sources such as Sigma Chemical Company (St Louis.
- Biological laboratory s test data trom a bodilv fluid or tissue ol an animal i e analyzed I he test data relates to at least one ot cell cv toioxicitv markers, cvtokme and chemokine levels immunoglobul in levels type and amount ol lv mphocvte subsets and ly mphocy te markers and markers ol neoplastic oi paraneoplastic change ol the animal I he value- should tail w ithin predetermined levels as a determinant ol the immune stimulation reaction neoplastic oi paraneoplastic change or the cellular mflammatorv response 0
- Methods for measuring ly mphokines and other cvtokines
- Test panels Nos 1 3 4 8 9 and 10 set out below can be used to obtain data tor this F xample 2
- C haracteristics related to inherited organ dvstunction or dv splasia ot the animal at least one ol w hich is neuronal neuromuscular or renal are determined
- Biological laboratory test data trom a bodilv fluid or tissue ot an animal are analyzed
- T e test data relate to an ammo acid carbohydrate lipid or other metabolic component body fluid or tissue marker ot the animal
- the data includes obtaining data related to at least one of the value of the 0 methvl malonic acid, the fucose-containing cell metabolites blood or urine urate or uric acid metabolites normoglvcem ic glycosu ⁇ a mannosidase containing cell metabolites, amino acid u ⁇ a amyloid deposition in tissues neuronal ceroid hpotuscin deposition, and deposition of ganghosides and other lv somal storage substrates of the animal
- the value should fall within predetermined levels as a determinant of
- Characteristics related to autoimmune thvroiditis ot the an imal are determined Biological laboratory test data from a bodily fluid or tissue of an animal are analyzed The test data relate to a genetic marker for automimmune thvroiditis of the animal The data relates to at least one of the results of a comprehensive thvroid antibody test profile.
- MHC major histocompatibility complex
- RFLP restriction fragment length polymorphism
- PCR polvmerase chain reaction
- SSO PCR sequence-specific oligonucleotides
- SSP PCR sequence-specific primers
- Test panels Nos I , 2, 3 and 10 set out below can be used to obtain data for this Example 4
- Example 5 Mammary Cancer Characteristics related to presence of or susceptibiltv to mammary cancer of the animal are determined
- test data relate to estrogen (estradiol- 17 ⁇ ) estrogen receptors mtei leukm (II ) 6 pr ogesterone and pr ogesterone receptors I he value- should fall within predetermined levels as .1 determinant ot the presence ol or susceptibiltv to mammarv cancer Pest panels Nos 1 2 3 and 10 set out below can be used to obtain data tor this I xample 5
- C haracteristics related to the tissue environment of the eve and brain which are sites protected trom the normal immunologic sur veillance mechanisms ar e determ ined
- Biological laboratoi v test data trom a bodilv fluid or tissue ol an animal are analvzed
- I he test data relate to the soluble and cellular immune inflammatory response mediators (cv tokme and chemokine levels immunoglobulin levels and Ivmphycyte susbset markers ) The value should fall within predetermined levels as a determinant ot integrity ot protected immune surveillance mechanisms
- Test panels Nos 1 3, 5 6 8, 9 and 10 set out below can be used to obtain data tor this Example 6
- Test panels Nos 1 , 7 and 9 set out below can be used to obtain data tor this Example 7
- Test 1 Comprehensive Diagnostic Test Panel
- CBC complete blood count
- platelet count platelet size platelet morphology serum chemistry profile [e g , AST (SGOT) ALT (SGOT) bihrubin (total, direct and indirect), alkaline phosphatase, GGT (GGTP) total protein albumin globulin.
- Test 2 Diagnostic Test Panels for Endocrine Function
- Dl A oi equivalent animal antigemc specificities ( RI I P PC R/SSO PC R/SSP) 2 ) Adrenal I unction eortisol (basal and after stimulation with AC I I I or serially after suppression with high or low-dose dexamethazone ) endogenous eortisol and endogenous AC Ti l i ) Reproductiv e I unction testosterone est ⁇ ad ⁇ ol- 1 71.
- ⁇ ntinuclear antibody ANA
- C oombs testing direct and indirect clution or microbeads gel-test
- rheumatoid factor serum electrophoresis - if abnormal run immunoelectrophoresis isoelect ⁇ c tocus
- immunoblotting Western Southern blots
- immunoglobulin levels IgG IgA IgM IgD and IgE
- complement levels C I C l a C l esterase inhibitor C3 C4 C5-C9
- Lh-prep testing lupus anticoagulant (dilute Russell s viper venom test or dilutional inhibitor test) urine protein SDS-gel electrophoresis fibronectin and anti-fibronectin antibodv flow cvtometrv with fluorescence activated cell sorter (FACS for leukocvte subsets and markers such as CD4 and CD8
- Test 4 Diagnostic Test Panels for Gastrointestinal Function and Nutritional Analysis
- ICP ion-coupled plasma emission spectroscopy
- Test 5 Diagnostic Test Panels for Inborn Errors of Metabolism haracteristics related to presence ot or susceptibiltv to mammat v cancel ol the animal at e determ ined Biological laboratory test data Iron, a bodilv flu id or tissue ol an animal ar e analy zed I he test data relate to estrogen ( estradiol- 17B) estrogen receptors mterleukin ( I I ) 6 progesterone and pr ogesterone receptoi s I he value should fall within predetermined levels as a determinant ot presence or susceptibiltv to mammary cancer Patient phenotvpic descriptors and genotv pic descriptors/background plus any or all selected tests tr om the lollowing list
- Test 6 Diagnostic Test Panels for Paternity Testing and DNA Fingerprinting
- Test 7 Diagnostic Test Panels for Hemostatrc and Coagulation Function
- Platelet count platelet size ( blood slide mean platelet volume), platelet morphology ( light scanning, and electron microscopy), prothrombin time partial thromboplastin time, fib ⁇ nogen. fib ⁇ n-fib ⁇ nogen degradation products (D-dimer test), platelet function tests (aggregation, release, clot retraction whole blood aggregation ⁇ stocetin cofactor). von Willebrand factor antigen and multimer analy sis, specific coagulation factor analyses ( factors I I V, VII VI I I C. IX. X XI. XI I. XI I I). fib ⁇ nolytic tests (plasminogen plasmin. antiplasmin.
- tissue plasminogen activator dilute whole blood lysis test euglobuhn lysis test ) anti-thrombin I I I test circulating anticoagulant tests, platelet factors 3 and 4 (heparin cofactor), protein C protein S. kinm-kinogen tests, prekallikrein test, alphai-antitrvpsin assay, alpha . -macroglobuhn assav. C
- Test 8 Diagnostic Test Panels for Vaccinal Antibodv Status, and Adverse Vaccine or Potential Adverse Vaccine Reaction
- Serology for Vaccinal Antibody canine distemper, canine parvovirus canine coronavirus, canine parainfluenza virus, infectious canine hepatitis virus, canine bordetella, canine Lyme (borreha), canine leptospirosis, rabies virus, feline panleukope a virus, feline leukemia virus, feline infectious peritonitis virus, feline immunodeficiency virus, feline cahcivirus, feline herpesvirus.
- Adverse Vaccine Reaction Same as l est 3 but especially C BC ANA C oombs test platelet count size and morphology anti-neutrophil cvtoplasmic antibody marker tor vaseulitis complement tests leukocyte chemotaxis tests urine pi otein/ereatinme ratio anti-platelet antibody immunoglobulin lev els especially lgG IgA IgM flow evtometrv ( I ACS) leukocyte subsets cell cvtotoxicitv analysis cvtokines especially s ehemokines. and complete thvroid autoantibody panel
- Test 9 Diagnostic Test Panels for Infectious Diseases
- RMSF Borre a species ( 1 v mc disease ) Bartonella species ( B henselae B vinsom i B e lar ⁇ dgeiae B kochlerae ) sy stemic fungal diseases (Coccidioides spp Crv ptococcus spp Fl istoplasma spp Blastomvces spp Aspergillus spp ringworm) mange mites (Demodex Sarcoptes Chvletiella etc ) enteric diseases (Clostndium perfringens enterotoxin) protozoan diseases (l oxoplasma spp Coccidia spp Giardia spp), 0 retrovirses ( feline leukemia virus feline immunodeficiency virus, equine infectious anem ia virus bovine leukemia virus caprine arthritis virus Corona viruses (canine coronavirus fel ine enteric coronavirus feline infectious peritonitis virus Babe
- Figure 1 is an overview of the web-based system to provide access to the invented database management 0 system With this system multiple users for instance, remote users 8 access the web site 4 using the Internet 6
- Each of the users 8 has a computer terminal with the appropriate software for accessing Internet
- the users 8 may be unknow n to the web server computers 1 0 and 12 1 ach usei 8 is al lowed to br ow se the web site and explore how the system f unctions
- a firewall 20 prevents anv user 8 li om accessing anv ol the components behind the firewall 20 s In th is wav the user s 8 have access to the web server computers 10 and 12 but on lv have access to the database- server 22 through the firewall 20
- I he database server 22 maintains among other things various database fields ith respect to each ol the health profiles ot subjects and the genetic information of a subject and groups
- I he- database 22 maintains the services with a designation associated to determine what health assessment data and genetic data can be browsed bv the users 8
- Each of the web server computers 1 0 and 12 allow usei s 8 to view
- the web server computers 10 and 12 can be identical and can be duplicated as additional load or growth on the svstem occurs
- the web server computers 10 and 12 share the responsibility for servicing the users of the site This arrangement provides tor expandabi lity ot the system bv merelv adding additional web server computers as necessary
- the svstem includes an appropriate computer terminal 24 lor interfacing w ith independent financial institutions which are connected on-line via the senal connection 26 to the financial institution computers 28
- This allows automatic real time confirmation of the access ot health profile and genetic data services and products
- a user requires access to a product or service the user goes through an identification or registration process and the exchange of financial information to allow for credit or debit card payment of the purchase This is 0 verified confirmed and authorized bv the appropriate bank svstem institution 28
- Confirmation ot the purchase or deposit of data or a service is made bv a mail server 34 which sends an E-mail to the user 8 confirming the purchase or deposit
- the mail server 34 allows tor mail to be received and sent out Security ot the various databases is maintained Alert messages are generated when an unauthorized access is attempted Verification messages, authorization messages and confirmation messages are generated as appropriate 5
- the database server 22 is also designed to interact with an input computer 32 operated bv a CDPR
- a firewall 30 serves to prevent unauthorized
- FIG. 2 is an illustration of the Internet and its use in the system of the invention
- the Internet 6 is a network of millions of interconnected computers 40 including systems owned by Internet providers 42 and 5 information systems 44 such as America Online (TM) Individual or corporate users may establish connections to the Internet in several ways
- a user on a home PC 46 may purchase an account through the Internet provider 42 Using a modem 48 the PC user can dial up the Internet provider to connect to a high speed modem 50 which, in turn, provides a full service connection to the Internet
- a user 52 may also make a somewhat limited connection to the Internet through a system 20 that provides an Internet gateway connection 54 and 56 to its customers
- the 0 database 22 is also connected into the Internet 6 through an appropriate modem or high speed or direct interface 58 I he database 22 is operable and maintained bv the DPR operatot computer 60 Usei s ol the databases ot the invention would access the Internet in an appropriately selected manner
- F igure 3 is a block diagram ol ⁇ II exemplary compute! svstem 100 lor practicing various aspects of the invention
- I he computer svstem 100 includes a displav screen or monitor 104 a printer 106 a disk drive 108 a s hard disk dnve 1 10 a nctwoi k interface 1 12 and a kevboai d 1 14
- he computer system 100 includes a microprocessor 1 16 a memory bus 1 1 8 random access memory (RAM) 129 read onlv memory (ROM) 122, a peripheral bus 124 and a keyboard controller 126
- I he computer svstem 100 can be a personal computer such as an Apple computer e an Apple Macintosh ( FM ) an IBM ( I M ) personal computer oi a compatible a workstation computer such as a Sun Microsystems (1 M) or Hewlett-Packard (TM ) workstation or some other tvpe 0 o
- Microprocessor 1 16 is a general purpose digital processor which controls the operation of computer system 100
- M icroprocessor I 16 can be a single-chip processor or can be implemented with multiple components Using instructions retrieve from memory the microprocessor I 16 controls the reception and manipulation of input data and the output and displav of data on output devices s
- Memory bus 1 88 is used bv the m icroprocessor 1 16 to access RAM 120 and ROM 122 RA M 129 is used by microprocessor 1 16 as a general storage area and as scratch-pad memory and can also be used to store input data and processed data ROM 122 can be used to store instructions or program code followed bv microprocessor 1 16 as well as other data
- Peripheral bus 124 is used to access the input, output, and storage devices used bv computer svstem 10 0 These devices include the displav screen 104 printer device 106 disk drive 108 hard disk drive I 10 and network interface 1 12
- the keyboard controller 126 is used to receive input from the keyboard 1 14 and send decoded symbols tor each pressed kev to microprocessor 1 16 over bus 128
- the display screen or monitor 104 is an output device that displays images of data provided by microprocessor I 16 via peripheral bus 124 or provided by other components in computer svstem 100
- the printer 5 device 106 when operating as a printer provides an image on a sheet ot paper or a similar surface
- Other output devices such as a plotter typesetter etc can be used in place of or in addition to the printer device 106
- the disk drive 108 and hard disk drive 1 10 can be used to store various tvpes ot data
- the disk drive 108 facilitates transporting such data to other computer sy stems and hard disk drive 1 10 permits fast access to large amounts of stored data 0
- Microprocessor 1 16 together with an operating system operate to execute computer code and produce and use data
- the computer code and data mav reside on RAM 120 ROM 122, or hard disk drive 120
- the computer code and data could also reside on a removable program medium and loaded or installed onto computer svstem 100 when needed
- Removable program mediums include, for example, CD-ROM PC-CARD, floppy disk and magnetic tape
- the network interface circuit 1 12 is used to send and receive data over a network connected to other computer systems
- An interface card or similar device and appropriate software implemented by microprocessor 1 16 can be used to connect computer system 100 to an existing network and transfer data according to standard protocols As such he computer system is connectable through an interface device with the Internet 6
- Keyboard 1 14 is used by a user to input commands and other instructions to computer system 100
- Other types of user input devices can also be used in conjunction with the present invention
- pointing devices such as a computer mouse a H ack ball a stvlus oi a tablet can be used to manipulate a pointer on a screen ol a general-purpose computer
- I he present invention in relation to the animal database management of data can also be embodied as computer readable code on a computer readable medium
- I he computer readable medium is anv data storage device s that can store data which can be thereafter read bv a computer svstem
- the computer readable medium include read-onlv memory random-access memory magnetic data storage devices such as diskettes and optical data storage devices such as C D-ROMs
- I he computer readable medium can also be distributed over networ k coupled computer sy stems so that the computer readable code is stored and executed in a distributed f ashion
- F igure 4 illustrates a browser system for use with the database system ot the invention
- a browser goes through a number ot prelim inary screens and logic steps, and reaches a screen 60 entitled "Next F ntrv”
- This screen provides data details or information generally indicated as 62 Clicking on anv ot these categories al lows the user to review database details 64 data specific details as generally indicated by 66 In this w ay the user can index through
- trigger 70 provides the user with information on how the process works, explains the system and provides details on how the user can participate in the database and obtain data or input data
- trigger 72 provides details regarding secu ⁇ tv of the svstem and automatic payment
- trigger 74 which can provide details of the extended data and explains that this may only be available on certain services or products
- Trigger 76 allows a user to pre-register and obtain user ID number This I D number is combined with financial information retained in the database in an encrypted form
- the pre-registration trigger 76 follows with step 78 which is to gather personal information such as credit card number and expirv date to allow for automatic 5 payment
- Step 80 is to validate a current existence in the database if this occurs With a negative answer the user is directed into a registration process indicate as 82 A user ID is assigned and a password is entered This information is maintained in a portion ot the database 22
- the user is provided a screen identifying the user I D at screen 86 I f the user alreadv exists, the registration process is rejected at 88 and the user is advised ot the information at the display 86
- the screen at 86 would also represent the information which is available in the 0 database 22
- FIG. 5 there is shown a basic block diagram of the components making up the CDPR
- the phenotype database or physical health database 200 and a genotype database or genetic information database 201 are contained in part of the overall CDPR database 202
- User input 203 can be obtained from a remote user such as a veterinarian, owner, breeder, or the operator of the database, an agent or researcher
- the output from the 5 database 204 could be to the veterinarian owner, breeder, operator, agent or researcher
- Figure 6 shows a relationship for retrieving data from the database 202
- the user 8 is represented here as a veterinarian, owner breeder, operator or researcher 203 who accesses the CDPR 202 accesses a first screen through a computer network 6 which inquires about information about the user An access request message is sent, and an appropriate access enabling message is transmitted
- the user 203 can obtain partial or full access to the CDPR 202 0 according to the scale of authority given to the user 203 to access data
- There is a computer program system 205 to ensure that payment is made as appropriate before access to the CDPR 202 is granted
- the i j .propi tate access code 204 can permit bypassing the payment requir ement 2()s as indicated by line 206 Pay ments " Os through the computer program can be effected by a credit card entrv and automatic transler to a financial institution on behalf ol the operator of the CDPR 202
- Such payment for access to the database is el lected bv a system which
- the genotvpe database 201 and other databases 207 208 and 209 respective ly [ he phenoty pic and genotv pic information together ith other database information can be presented on a single screen or monitor or other viewing means tor instance hard copv format I he access therefore can be to multiple databases contained within the C DPR 202
- he user accessing the phvsical health database 200 the user obtains an analysis report from module 2 10 1 he user is then able to read the analysis as indicated bv 21 1 and output the analysis Irom the read-out 2 1 1 as indicated bv output 2 12 T he output 2 12 can be a computer screen read-out tax or voice information
- the phvsical health or phenotvpe database 200 is subject or group spec ific In other words the data obtained in that database is specific to a particular animal or animal group ( breed lam ilv species etc ) which has been the
- I s subject ot a laboratory or research biological examination such that flu id or tissue samples have been subject to analysis in one or more laboratory or research environments t hese biological reports can include those trom specimens ot blood urine other bodv fluids skin eyes skeletal and other tissues Hie P I database 200 has the abi lity to store the subject specific information as required within the CDPR 202
- the genotype specific or genetic disorder or disease data is retained in the database 201 within the CDPR 0 database 202 This data is either subject specific family specific breed specific species specific disorder specific or disease specific and is group or subject specific
- the user can access the genoty pe database 201 and obtain a read-out 2 13 w hich can then be transm itted along line 2 14 to an output 2 12 in the same manner that the physical health assessment is obtained as an output
- the reader can request an analysis 2 15 from the genotvpe database as indicated by 5 line 2 16
- This analysis can receive data along line 2 17 from the analy sis information of the physical health assessment
- Interpretation of the PT and GT can be obtained as indicated bv 2 1 8 and this can then be outputted as indicated along line 219
- the interpretation ot PT and GT 2 1 8 can be performed bv an algorithm relating to the coefficients and predictability of information relating to disorders disease and longevity when considering the data from the two databases PT 200 and GT 201
- This can be done automatically and outputted along line 2 19 or there 0 can be an expert interface 220 using skilled personnel to interpret the data of block 2 1 8 and this can in turn be outputted along line 221 to the output 212
- Database 207 can be a genetic marker database and the information from that database can be directly input into the output through a read-out 222 and 223 to the output 212 Alternatively the data from database 207 can be added to the interpretation section 218 of the physical health and genetic information by directing the data along line 5 224 This data can then be made the subject of the output along the line 2 19 and 221 as required
- the output 2 1 2 provides a compilation w h ich combines the physical health and genetic s in f ormation relating to a subject the bt eed disease disorder and l if e-span ther eby enabling the reeeiver ot the output 2 12 to use the compiled in formation in a manner to facilitate breeding criteria
- w hich can be important in i clation to animals w h ich ai e usually inbr ed or line bred I he in f ormation can also be used to facilitate on-going monitoring ol pai ticular subject an imals I he data Irom this system can be used to manipulate and regulate breeding health and longevity effectively among animals
- the svstem of the invention is further described with regard to F igure 7 w hich is a system tor inputting data to the CDPR 202
- multiple users 203 which can be a remote user such as a laboratorv a breeder an owner hospital, agent or an operator of the CDPR 202 accesses the svstem through module 204 which in turn accesses the CDPR 202
- Appropriate access i cquest and access enable messages are sent
- the C DPR 202 there is a physical health or phenotvpe module 200 a genetic or genoty pe data module 201 and other database modules 207
- the stored data in each of the blocks 200 20 1 and 207 can be set up as indicated bv block 232 in a manner 0 which is restricted or unrestricted to selected users 203 This mav be necessarv according to the protocols governing the inputted data to the different databases In some cases the w aiving of deposit tees is made in the interest of freedom ot the database to subsequent users who wish to retrieve data trom the database After storage ot the data as indicated by block 234 the user 203 exits CDPR 202 as indicated bv block 233
- the genetic influence on behavior and behavioral disorders accounts tor less than half of the phenotypic expression of behavior and behavioral differences
- behavior is the most complex phenotype, because it reflects not only the functioning of the whole being but also is dynamic and changes in response to environmental influences
- results are most dramatically seen in purebred animals because they have been 0 inbred and line-bred to select for a particular behavior and conformation, even though the genotype of purebred bl eeds shows almost no var iation ovei 100 y ear s I xamples ol this ai e all the dil lei ent pur ebr ed dog breeds which e urrentlv ex ist and have widely disparate size weight temperament and life-spans
- the phenotv pic database indicates elevated blood and urine glucose leve ls then by relating this to the genotvpic and combined database categories ot weight age sex breed and reproductive history it is possible to determine that the subject has diabetes that is hkelv to be ot an heritable basis
- Another example relates the phenotvpic database indicating low blood von Willebrand factor level to the genotvpic and combined database categories ot breed, age sex and clinical and family history w hereby it is possible to determ ine whether the subject has the inherited or acquired form of von Wi llebrand disease
- I s An exemplary server performs all the operations ot a conventional database sy stem and performs additional operations in accordance with the present invention as has been discussed
- I he server includes a central processing unit (C PU ) together w ith associated memorv tor processing intormation about different animals species and history
- I he inquiries concern animals species and history and inquiries and requests for health profiling and genetic intormation and providing health profiles and genetic information
- the CPU is coupled to the database and to users 0 v ia a communications port
- the CPU is also coupled to an electronic mail processor for processing and storing (in a storage device ) e-mai l messages transmitted betw een the CPU and various agents users and the like [ he CPU is further coupled to a data storage device
- a data storage dev ice may include a variety ot the databases I he svstem permits for the requesting storing and providing of data with respect to animal phenotvpic information and genetic information
- the desired data is based on the submission of test specimens of a specific animal to the laboratorv
- health profile test data 200 can be inputted into the CDPR 202 having the genetic database 201
- the CDPR 202 can perform an analysis and correlation between the health profile 5 database 200 and the genetic database 201
- the remote user 8 uses the communications link to communicate w ith the laboratory or the CDPR 202 Specimens can be packaged and physically transported to the laboratory site via commercially available common carriers, such as the postal service or courier services When the packages arrive the laboratory places them in storage, or the tests are performed Instruments 300 perform the tests to obtain data as specified by the remote 0 user 8
- the biohazardous samples can be disposed of a waste material
- the test results, or output is provided as part of a health profile database 200 of the CDPR 202 and is available to the remote user 8 I I desired the remote usei 8 can arrange to have the data stoi ed in the C DPR 202 made avai lable to olhei r emote user s 8 I he remote user 8 can also r equest the laboratorv to perf orm analysis on the health profi le data 200 generated
- the communications link is a computer networ k and the message tiansler modality is lor instance the Internet 6 and/oi an Intranet and or an I xtranet I he netw oi k sy stems ar e par ticular ly suited to the application described herein since it ot ters global or widespread accessibi lity and high speed data transfer of large- amounts ol information
- a security unit allows remote users to designate who has perm ission to view or use their data I easible options tor these intormation management requirements include access bv the subm itting remote users on lv access 10 bv certain designated researchers and col laborators time-embargoed data followed bv wider access and unrestricted access bv all ⁇ commerce unit can implement functions related to the business aspects ot the C DPR lacihtv including billing inventory management ot support materials
- the operations performed bv the present invention begins w hen the controller receives an access request message from the remote user via a communication link Using information in the access request message and any other available intormation the controller determines if the remote user is authorized to access the CDPR 202 If so 0 an access enabling message is transmitted trom the controller to the remote user 8
- the access enabling message can comprise a set of computer instructions transm itted over the internet 6 w hich is down loaded into the remote user memorv tor execution by the remote user processor These instructions may be enabling that is thev mav allow direct communication between the remote user 8 and the CDPR 202 with no further need for the controller
- the access enabling message mav simply comprise a password or other enabling message 5 w hich allows the remote user 8 to proceed
- the remote user 8 can access or submit data to the CDPR 202 according to different protocols and regimes and security arrangements
- the sy stem also perm its for the access to the genetic and'or phenotvpe data through a passw ord and a svstem v. hereby access to the data generates a lee
- This sv stem perm its for the access or to provide data w ith r egard to credit cards or the like to ensure that the tee is transmitted automatically to a banking sy stem tor the account ot the database I s w hen such data is accessed
- 1 h is sv stem also provides tor a situation w herein pay ments can be made bv credit card lor requests to perto ⁇ n health assessment profiles and secure genom ic mapping and genetic screening information
- bioinformatics system can also permit for the automatic payment tor such services and products to the banking system ot the database or laboratory
- the database mav require that the payments be guaranteed, for instance bv supplying a credit 0 card number with a request for performance of services and a product and tor the retrieval of such data
- a user can submit a request to the database in anv number ot way s
- the request can be submitted via on-line direct connection namelv through a computer network such as the Internet
- An intermediate researcher such as a veterinarian or scientist other than the owner could also submit the request on behalt of the owner using the e- mail capabilities ot the central database system
- the user can subm it the data via an interactive voice 5 response unit coupled to the database svstem of the supplier
- the database supplier can decide whether to supply the health assessment information and/or genomic mapping and genetic sei eening information based on the criteria ot the user or its intermediary agent
- Such user or intermediary agent can be notified ot the decision via the interactive response unit or a live operator
- the user or agent can log into the database system and obtain the necessary records relating to an animal 0 phvsical health and/or genetic ancestry or offspring
- the database system can transmit in real time or on a periodic basis as determined, thereby, providing information regarding the health assessment or the genetic background and forward this information to the user and/or its intermediary agent
- the data storage devices of the invention include a variety of databases including a database relating to the phenotypic data of a particular species a database relating to health assessment or other phenotypic data of particular 5 animals in a particular species, and genetic characteristics of different species and different family trees relating to different species
- the family trees would contain information including the origin, genomic map, and parental lines of a species and records of health and performance of a species
- These databases are interrelated in an analytical manner and in accordance with different algorithms of permutations and probabilities to facilitate useful output information based on the combination of data in the genotypic and the phenotypic databases, and the selected databases 0
- Many other examples of the invention exist, each differing from others in matters of detail only The invention is to be determined solely by the following claims Relerences
- Stefanon, G Stefanon, B Stefanon. G G Dodds. W J Inherited and Acquired Bleeding Disorders in Northeastern Italy Can Pract 18(3), 15-23, 1993
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioethics (AREA)
- Databases & Information Systems (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001531017A JP2003523176A (en) | 1999-10-15 | 2000-09-22 | Animal health check |
AU78308/00A AU782474B2 (en) | 1999-10-15 | 2000-09-22 | Animal health diagnosis |
EP00968382A EP1223852A4 (en) | 1999-10-15 | 2000-09-22 | Animal health diagnosis |
CA2387780A CA2387780C (en) | 1999-10-15 | 2000-09-22 | Animal health diagnosis |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/419,192 US6730023B1 (en) | 1999-10-15 | 1999-10-15 | Animal genetic and health profile database management |
US09/419,192 | 1999-10-15 | ||
US09/432,851 | 1999-11-02 | ||
US09/432,851 US6287254B1 (en) | 1999-11-02 | 1999-11-02 | Animal health diagnosis |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001028415A1 true WO2001028415A1 (en) | 2001-04-26 |
Family
ID=27024381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/025924 WO2001028415A1 (en) | 1999-10-15 | 2000-09-22 | Animal health diagnosis |
Country Status (6)
Country | Link |
---|---|
US (2) | US6537213B2 (en) |
EP (1) | EP1223852A4 (en) |
JP (1) | JP2003523176A (en) |
AU (1) | AU782474B2 (en) |
CA (1) | CA2387780C (en) |
WO (1) | WO2001028415A1 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002090579A1 (en) * | 2001-05-04 | 2002-11-14 | Genomics Research Partners Pty Ltd | Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression |
WO2002093453A2 (en) * | 2001-05-12 | 2002-11-21 | X-Mine, Inc. | Web-based genetic research apparatus |
EP1260927A2 (en) * | 2001-05-25 | 2002-11-27 | Hitachi, Ltd. | Information processing system using nucleotide sequence-related information |
WO2004017066A1 (en) | 2002-08-16 | 2004-02-26 | Lattec I/S | A system and a method for observing and predicting physiological state of an animal |
EP1411825A2 (en) * | 2001-07-02 | 2004-04-28 | Hemopet | Animal healthcare, well-being and nutrition |
WO2004044236A1 (en) * | 2002-11-14 | 2004-05-27 | Genomics Research Partners Pty Ltd | Status determination |
EP1455287A1 (en) * | 2001-11-22 | 2004-09-08 | Hitachi, Ltd. | Information processing system using information on base sequence |
EP1553512A1 (en) * | 2002-07-15 | 2005-07-13 | Hitachi Ltd. | Information processing system using base sequence relevant information |
EP1578904A2 (en) * | 2001-09-21 | 2005-09-28 | Access Genetics, LLC | Systems, methods and kits for remote genetic analysis and consultation |
US7302349B2 (en) | 2002-08-16 | 2007-11-27 | Lattec I/S | System and a method for observing and predicting a physiological state of an animal |
US7548839B2 (en) * | 1999-10-15 | 2009-06-16 | Hemopet | System for animal health diagnosis |
US7552039B2 (en) * | 1999-10-15 | 2009-06-23 | Hemopet | Method for sample processing and integrated reporting of dog health diagnosis |
US7729863B2 (en) | 2003-12-17 | 2010-06-01 | Fred Hutchinson Cancer Research Center | Methods and materials for canine breed identification |
US7873482B2 (en) | 2008-12-16 | 2011-01-18 | Bruno Stefanon | Diagnostic system for selecting nutrition and pharmacological products for animals |
US8060354B2 (en) | 1999-10-15 | 2011-11-15 | Hemopet | System and method for determining a nutritional diet for a canine or feline animal |
US8224587B1 (en) | 1999-10-15 | 2012-07-17 | Hemopet | Method and system for determining a nutritional diet for a canine or feline animal |
US8594948B2 (en) | 2002-09-18 | 2013-11-26 | Ronald C. McGlennen | Apparatus and methods for medical testing |
US20140163895A1 (en) * | 2012-12-12 | 2014-06-12 | Noam Pik | System and method for assessing health risk for mixed breed animals |
CN104543416A (en) * | 2013-10-09 | 2015-04-29 | 中国科学院大连化学物理研究所 | Functional monosaccharide feed for adjusting reproductive performance of female animals and application thereof |
CN112237156A (en) * | 2020-10-23 | 2021-01-19 | 宁波大学 | Device and experimental method for testing autonomous social behaviors of small animals |
EP4064287A1 (en) | 2021-03-24 | 2022-09-28 | ZuchtData EDV Dienstleistungen GmbH | Method for predicting diseases of farm animals |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2387780C (en) * | 1999-10-15 | 2011-10-11 | W. Jean Dodds | Animal health diagnosis |
US20050090718A1 (en) * | 1999-11-02 | 2005-04-28 | Dodds W J. | Animal healthcare well-being and nutrition |
US7596578B1 (en) | 1999-11-23 | 2009-09-29 | Expert Viewpoint, Llc | Method and apparatus for operating and funding a question and answer interactive system |
US7418437B1 (en) * | 1999-11-23 | 2008-08-26 | Expert Viewpoint Llc | System and method for supporting multiple question and answer fora in different web sites |
US7472071B2 (en) * | 1999-11-23 | 2008-12-30 | Expertviewpoint Llc. | Interactive system for managing questions and answers among users and experts |
JP4118674B2 (en) * | 2000-09-06 | 2008-07-16 | 株式会社日立製作所 | Abnormal behavior detection device |
EP1213638A1 (en) * | 2000-12-06 | 2002-06-12 | Siemens Aktiengesellschaft | Enabling devices |
DE10132767A1 (en) * | 2001-07-10 | 2003-01-30 | Christian Koeppel | Identification of animal, plant and rock specimens using e.g. mobile phone, employs menu operation to search databank presenting characteristics in rows, and forms in columns |
US7155377B2 (en) * | 2001-08-23 | 2006-12-26 | Wisconsin Alumni Research Foundation | Method and system for calculating the spatial-temporal effects of climate and other environmental conditions on animals |
US7603284B2 (en) * | 2002-02-07 | 2009-10-13 | Micro Beef Technologies, Ltd. | Livestock management systems and methods |
US6932024B2 (en) * | 2003-01-09 | 2005-08-23 | Cargill, Incorporated | Compact pedigrees showing heritable traits for many individuals |
US20060147962A1 (en) * | 2003-06-16 | 2006-07-06 | Mars, Inc. | Genotype test |
US20050065736A1 (en) * | 2003-07-15 | 2005-03-24 | Bauck Stewart William | Systems and methods for improving efficiencies in livestock production |
US20050071192A1 (en) * | 2003-09-30 | 2005-03-31 | Nada Milosavljevic | Quick notation medical reference and record system and method of use |
AU2005325748A1 (en) * | 2004-05-28 | 2006-08-03 | American Canine Association, Inc. | Internet based animal registration system |
JP4679843B2 (en) * | 2004-07-02 | 2011-05-11 | シスメックス株式会社 | Hematology analyzer and analysis program |
US7835922B2 (en) * | 2004-07-08 | 2010-11-16 | Astrazeneca Ab | Diagnostic system and method |
CN101189514B (en) * | 2004-08-30 | 2013-05-29 | 希尔氏宠物营养品公司 | Genome-based diet design |
US7543549B2 (en) * | 2004-09-14 | 2009-06-09 | Lextron, Inc. | Cattle management system and method |
US7441515B2 (en) * | 2004-09-14 | 2008-10-28 | Lextron, Inc. | Cattle management system and method |
US7860659B2 (en) * | 2004-09-17 | 2010-12-28 | Bionutritional, Llc | Methods and systems for providing a nutraceutical program specific to an individual animal |
US7409297B2 (en) * | 2004-09-17 | 2008-08-05 | Bionutritional, Llc | Methods and systems for providing a nutraceutical program specific to an individual animal |
US20070118295A1 (en) * | 2005-03-02 | 2007-05-24 | Al-Murrani Samer Waleed Khedhe | Methods and Systems for Designing Animal Food Compositions |
US20060235282A1 (en) * | 2005-03-17 | 2006-10-19 | Helen Wesolowski | Methods for the treatment of mammals with abnormal glucose tolerance |
US7406453B2 (en) * | 2005-11-04 | 2008-07-29 | Microsoft Corporation | Large-scale information collection and mining |
US20070112796A1 (en) * | 2005-11-17 | 2007-05-17 | Jung Edward K | Research in providing assistance related to health |
US8532938B2 (en) * | 2005-11-17 | 2013-09-10 | The Invention Science Fund I, Llc | Testing-dependent administration of a nutraceutical |
US20070119928A1 (en) * | 2005-11-17 | 2007-05-31 | Jung Edward K | Generating a nutraceutical request from an inventory |
US20070112592A1 (en) * | 2005-11-17 | 2007-05-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Payments in providing assistance related to health |
US10042980B2 (en) * | 2005-11-17 | 2018-08-07 | Gearbox Llc | Providing assistance related to health |
US20070124176A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US20070136092A1 (en) * | 2005-11-30 | 2007-06-14 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging |
US8340944B2 (en) * | 2005-11-30 | 2012-12-25 | The Invention Science Fund I, Llc | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US8068991B2 (en) * | 2005-11-30 | 2011-11-29 | The Invention Science Fund I, Llc | Systems and methods for transmitting pathogen related information and responding |
US8297028B2 (en) * | 2006-06-14 | 2012-10-30 | The Invention Science Fund I, Llc | Individualized pharmaceutical selection and packaging |
US20070299693A1 (en) * | 2006-06-23 | 2007-12-27 | Searete Llc, A Limited Liability Corporation | Customized visual marking for medication labeling |
US20080082272A1 (en) * | 2005-11-30 | 2008-04-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods related to nutraceuticals |
US20080004909A1 (en) * | 2005-11-30 | 2008-01-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems related to nutraceuticals |
US7827042B2 (en) | 2005-11-30 | 2010-11-02 | The Invention Science Fund I, Inc | Methods and systems related to transmission of nutraceutical associated information |
US7974856B2 (en) * | 2005-11-30 | 2011-07-05 | The Invention Science Fund I, Llc | Computational systems and methods related to nutraceuticals |
US8000981B2 (en) * | 2005-11-30 | 2011-08-16 | The Invention Science Fund I, Llc | Methods and systems related to receiving nutraceutical associated information |
US20070124175A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware. | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US20080193919A1 (en) * | 2005-11-30 | 2008-08-14 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and methods for receiving pathogen related information and responding |
US10296720B2 (en) * | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
US7927787B2 (en) * | 2006-06-28 | 2011-04-19 | The Invention Science Fund I, Llc | Methods and systems for analysis of nutraceutical associated components |
US20070124218A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized nutraceutical selection and packaging |
CN101365489A (en) * | 2005-12-12 | 2009-02-11 | 希尔氏宠物营养品公司 | Method for deriving a wellness related index for a food composition |
WO2008002322A2 (en) * | 2005-12-20 | 2008-01-03 | Searete Llc | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
WO2007075932A2 (en) * | 2005-12-20 | 2007-07-05 | Mars, Incorporated | Method and system for determining and providing a comprehensive pet health and nutrition feeding plan |
EP1820407A1 (en) * | 2006-02-17 | 2007-08-22 | Nestec S.A. | Method for improving dog food |
WO2007103886A2 (en) * | 2006-03-03 | 2007-09-13 | Fort Supply Ip, Llc | System and method for social group management |
US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
US7533070B2 (en) * | 2006-05-30 | 2009-05-12 | Honeywell International Inc. | Automatic fault classification for model-based process monitoring |
US20080040157A1 (en) * | 2006-08-14 | 2008-02-14 | Brent Saunders | Methods and systems for storing and providing information related to companion animals |
CA2702408C (en) * | 2007-10-12 | 2019-08-06 | Patientslikeme, Inc. | Self-improving method of using online communities to predict health-related outcomes |
WO2009079511A1 (en) * | 2007-12-17 | 2009-06-25 | Mars, Incorporated | Wellness based pet diets that take into consideration breed type and genetic predisposition of a pet |
US7799532B2 (en) * | 2008-11-12 | 2010-09-21 | Hemopet | Detection and measurement of thyroid hormone autoantibodies |
US7794954B2 (en) * | 2008-11-12 | 2010-09-14 | Hemopet | Detection and measurement of thyroid analyte profile |
US8012769B2 (en) * | 2008-11-12 | 2011-09-06 | Hemopet | Thyroid analyte detection and measurement |
US20100151062A1 (en) * | 2008-12-16 | 2010-06-17 | Bruno Stefanon | Determining nutrients for animals through gene expression |
US20100191735A1 (en) * | 2008-12-18 | 2010-07-29 | University Of Utah | Systems and methods for classifying and screening biological materials for use for therapeutic and/or research purposes |
US8450074B2 (en) * | 2009-01-26 | 2013-05-28 | W. Jean Dodds | Multi-stage nutrigenomic diagnostic food sensitivity testing in animals |
US7867720B2 (en) * | 2009-01-26 | 2011-01-11 | Dodds W Jean | Food sensitivity testing in animals |
US7892763B2 (en) * | 2009-01-26 | 2011-02-22 | Dodds W Jean | Multi-stage nutrigenomic diagnostic food sensitivity testing in animals |
EP2430574A1 (en) | 2009-04-30 | 2012-03-21 | Patientslikeme, Inc. | Systems and methods for encouragement of data submission in online communities |
WO2011046595A1 (en) * | 2009-10-15 | 2011-04-21 | Nestec S.A. | Methods for identifying animals with a reduced ability to digest lipid and protein |
JP2011190225A (en) * | 2010-03-16 | 2011-09-29 | Fujifilm Corp | Antibody to dog tsh beta chain peptide |
WO2012027519A2 (en) * | 2010-08-27 | 2012-03-01 | The Iams Company | Methods of measuring activities of daily living |
EP2643765B1 (en) | 2010-11-15 | 2018-08-08 | Ecotech Marine, LLC | Apparatus and methods for controlling a habitat environment |
US9526437B2 (en) | 2012-11-21 | 2016-12-27 | i4c Innovations Inc. | Animal health and wellness monitoring using UWB radar |
WO2014134606A1 (en) * | 2013-03-01 | 2014-09-04 | Cleverpet Llc | Animal interaction device, system, and method |
US10149617B2 (en) | 2013-03-15 | 2018-12-11 | i4c Innovations Inc. | Multiple sensors for monitoring health and wellness of an animal |
CA2951374C (en) | 2014-07-08 | 2023-03-21 | Mark A. Donavon | Systems and methods for providing animal health, nutrition, and/or wellness recommendations |
WO2016186524A1 (en) * | 2015-05-21 | 2016-11-24 | Heyrex Limited | Animal weight management |
CN107897031A (en) * | 2017-11-07 | 2018-04-13 | 宁波云极信息科技有限公司 | A kind of pet care method |
US20210190781A1 (en) * | 2018-03-17 | 2021-06-24 | University Of Central Florida Research Foundation, Inc. | Detection of Interaction Between an Assay Substance and Blood or Blood Components for Immune Status Evaluation and Immune-Related Disease Detection and Diagnosis |
US11894139B1 (en) | 2018-12-03 | 2024-02-06 | Patientslikeme Llc | Disease spectrum classification |
JP7236974B2 (en) * | 2019-10-03 | 2023-03-10 | 富士フイルム株式会社 | Medical support device, medical support method, and medical support program |
GB2608502A (en) | 2019-11-18 | 2023-01-04 | Embark Veterinary Inc | Methods and systems for determining ancestral relatedness |
JP7299143B2 (en) * | 2019-11-25 | 2023-06-27 | 富士フイルム株式会社 | ANIMAL HEALTH RISK ASSESSMENT SYSTEM AND ANIMAL HEALTH RISK ASSESSMENT METHOD |
KR102274263B1 (en) * | 2021-03-09 | 2021-07-08 | 한국축산데이터 주식회사 농업회사법인 | Livestock health status immune standardization system |
KR102690267B1 (en) | 2021-10-25 | 2024-08-06 | 농업회사법인 지팜 유한회사 | Piglet status analysis method and device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817025A (en) * | 1996-09-30 | 1998-10-06 | Alekseev; Sergei Grigorevich | Method for diagnosing malignancy diseases |
US5830709A (en) * | 1989-10-27 | 1998-11-03 | Benson; Roger E. | Detection method for homologous portions of a class of substances |
US5911687A (en) * | 1995-11-15 | 1999-06-15 | Hitachi, Ltd. | Wide area medical information system and method using thereof |
US6081786A (en) * | 1998-04-03 | 2000-06-27 | Triangle Pharmaceuticals, Inc. | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6232522B1 (en) | 1990-01-31 | 2001-05-15 | Oklahoma Medical Research Foundation | Non-human animal model for systemic lupus erythematosis |
US5692501A (en) * | 1993-09-20 | 1997-12-02 | Minturn; Paul | Scientific wellness personal/clinical/laboratory assessments, profile and health risk managment system with insurability rankings on cross-correlated 10-point optical health/fitness/wellness scales |
US5673647A (en) | 1994-10-31 | 1997-10-07 | Micro Chemical, Inc. | Cattle management method and system |
ATE197511T1 (en) * | 1995-07-25 | 2000-11-11 | Horus Therapeutics Inc | COMPUTER-ASSISTED METHOD AND ARRANGEMENT FOR DIAGNOSING DISEASES |
US6136055A (en) | 1995-08-14 | 2000-10-24 | Emerson Electric Co. | Self-contained portable/mountable air cleaner |
US5691157A (en) | 1995-10-24 | 1997-11-25 | The Research Foundation Of State University Of New York | Method for detecting a mammal's prior exposure to radiation or radiomimetic chemicals |
US5954640A (en) * | 1996-06-27 | 1999-09-21 | Szabo; Andrew J. | Nutritional optimization method |
US6063028A (en) | 1997-03-20 | 2000-05-16 | Luciano; Joanne Sylvia | Automated treatment selection method |
WO1999004043A1 (en) * | 1997-07-14 | 1999-01-28 | Abbott Laboratories | Telemedicine |
US6018786A (en) | 1997-10-23 | 2000-01-25 | Intel Corporation | Trace based instruction caching |
US6218122B1 (en) | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
US6358546B1 (en) * | 1999-01-15 | 2002-03-19 | Ralston Purina Company | Methods for customizing pet food |
CA2387780C (en) | 1999-10-15 | 2011-10-11 | W. Jean Dodds | Animal health diagnosis |
US6730023B1 (en) | 1999-10-15 | 2004-05-04 | Hemopet | Animal genetic and health profile database management |
US6287254B1 (en) | 1999-11-02 | 2001-09-11 | W. Jean Dodds | Animal health diagnosis |
-
2000
- 2000-09-22 CA CA2387780A patent/CA2387780C/en not_active Expired - Fee Related
- 2000-09-22 AU AU78308/00A patent/AU782474B2/en not_active Ceased
- 2000-09-22 JP JP2001531017A patent/JP2003523176A/en not_active Withdrawn
- 2000-09-22 EP EP00968382A patent/EP1223852A4/en not_active Withdrawn
- 2000-09-22 WO PCT/US2000/025924 patent/WO2001028415A1/en active Search and Examination
-
2001
- 2001-07-02 US US09/898,193 patent/US6537213B2/en not_active Expired - Lifetime
-
2003
- 2003-02-03 US US10/356,885 patent/US7029441B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830709A (en) * | 1989-10-27 | 1998-11-03 | Benson; Roger E. | Detection method for homologous portions of a class of substances |
US5911687A (en) * | 1995-11-15 | 1999-06-15 | Hitachi, Ltd. | Wide area medical information system and method using thereof |
US5817025A (en) * | 1996-09-30 | 1998-10-06 | Alekseev; Sergei Grigorevich | Method for diagnosing malignancy diseases |
US6081786A (en) * | 1998-04-03 | 2000-06-27 | Triangle Pharmaceuticals, Inc. | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
Non-Patent Citations (1)
Title |
---|
See also references of EP1223852A4 * |
Cited By (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8234099B2 (en) | 1999-10-15 | 2012-07-31 | Hemopet | Computer program for determining a nutritional diet product for a canine or feline animal |
US7797145B2 (en) | 1999-10-15 | 2010-09-14 | Dodds W Jean | Animal health diagnostics |
US7552039B2 (en) * | 1999-10-15 | 2009-06-23 | Hemopet | Method for sample processing and integrated reporting of dog health diagnosis |
US7548839B2 (en) * | 1999-10-15 | 2009-06-16 | Hemopet | System for animal health diagnosis |
US7865343B2 (en) * | 1999-10-15 | 2011-01-04 | Dodds W Jean | Method of analyzing nutrition for a canine or feline animal |
US8060354B2 (en) | 1999-10-15 | 2011-11-15 | Hemopet | System and method for determining a nutritional diet for a canine or feline animal |
US8224587B1 (en) | 1999-10-15 | 2012-07-17 | Hemopet | Method and system for determining a nutritional diet for a canine or feline animal |
EP1402062A4 (en) * | 2001-05-04 | 2005-09-07 | Genomics Res Partners Pty Ltd | Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression |
EP1402062A1 (en) * | 2001-05-04 | 2004-03-31 | Genomics Research Partners Pty Ltd | Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression |
WO2002090579A1 (en) * | 2001-05-04 | 2002-11-14 | Genomics Research Partners Pty Ltd | Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression |
WO2002093453A2 (en) * | 2001-05-12 | 2002-11-21 | X-Mine, Inc. | Web-based genetic research apparatus |
WO2002093453A3 (en) * | 2001-05-12 | 2004-03-11 | Mine Inc X | Web-based genetic research apparatus |
US7945389B2 (en) | 2001-05-25 | 2011-05-17 | Hitachi, Ltd. | Information processing system using nucleotide sequence-related information |
EP1260927A3 (en) * | 2001-05-25 | 2006-06-21 | Hitachi, Ltd. | Information processing system using nucleotide sequence-related information |
US7912650B2 (en) | 2001-05-25 | 2011-03-22 | Hitachi, Ltd. | Information processing system using nucleotide sequence-related information |
KR100832077B1 (en) * | 2001-05-25 | 2008-05-27 | 가부시끼가이샤 히다치 세이사꾸쇼 | Information processing system using nucleotide sequence-related information |
US8571810B2 (en) | 2001-05-25 | 2013-10-29 | Hitachi, Ltd. | Information processing system using nucleotide sequence-related information |
EP1260927A2 (en) * | 2001-05-25 | 2002-11-27 | Hitachi, Ltd. | Information processing system using nucleotide sequence-related information |
US8103368B2 (en) | 2001-05-25 | 2012-01-24 | Hitachi, Ltd. | Information processing system using nucleotide sequence-related information |
EP1411825A2 (en) * | 2001-07-02 | 2004-04-28 | Hemopet | Animal healthcare, well-being and nutrition |
EP1411825A4 (en) * | 2001-07-02 | 2010-04-14 | Hemopet | Animal healthcare, well-being and nutrition |
EP1578904A2 (en) * | 2001-09-21 | 2005-09-28 | Access Genetics, LLC | Systems, methods and kits for remote genetic analysis and consultation |
EP1578904A4 (en) * | 2001-09-21 | 2007-11-21 | Access Genetics Llc | Systems, methods and kits for remote genetic analysis and consultation |
US8126655B2 (en) | 2001-11-22 | 2012-02-28 | Hitachi, Ltd. | Information processing system using information on base sequence |
EP1455287A4 (en) * | 2001-11-22 | 2006-08-16 | Hitachi Ltd | Information processing system using information on base sequence |
US9607126B2 (en) | 2001-11-22 | 2017-03-28 | Hitachi, Ltd. | Information processing system using nucleotide sequence-related information |
EP1455287A1 (en) * | 2001-11-22 | 2004-09-08 | Hitachi, Ltd. | Information processing system using information on base sequence |
US8639451B2 (en) | 2001-11-22 | 2014-01-28 | Hitachi, Ltd. | Information processing system using nucleotide sequence-related information |
US7747394B2 (en) | 2002-07-15 | 2010-06-29 | Hitachi, Ltd. | Information processing system using base sequence relevant information |
EP1553512A4 (en) * | 2002-07-15 | 2006-06-28 | Hitachi Ltd | Information processing system using base sequence relevant information |
US8364416B2 (en) | 2002-07-15 | 2013-01-29 | Hitachi, Ltd. | Information processing system using base sequence relevant information |
EP1553512A1 (en) * | 2002-07-15 | 2005-07-13 | Hitachi Ltd. | Information processing system using base sequence relevant information |
US7676346B2 (en) | 2002-08-16 | 2010-03-09 | Lattec I/S | System and a method for observing and predicting a physiological state of an animal |
US7302349B2 (en) | 2002-08-16 | 2007-11-27 | Lattec I/S | System and a method for observing and predicting a physiological state of an animal |
WO2004017066A1 (en) | 2002-08-16 | 2004-02-26 | Lattec I/S | A system and a method for observing and predicting physiological state of an animal |
US8594948B2 (en) | 2002-09-18 | 2013-11-26 | Ronald C. McGlennen | Apparatus and methods for medical testing |
WO2004044236A1 (en) * | 2002-11-14 | 2004-05-27 | Genomics Research Partners Pty Ltd | Status determination |
US7729863B2 (en) | 2003-12-17 | 2010-06-01 | Fred Hutchinson Cancer Research Center | Methods and materials for canine breed identification |
US7970552B1 (en) | 2008-12-16 | 2011-06-28 | Bruno Stefanon | Diagnostic system for selecting nutrition and pharmacological products for animals |
US7873482B2 (en) | 2008-12-16 | 2011-01-18 | Bruno Stefanon | Diagnostic system for selecting nutrition and pharmacological products for animals |
US20140163895A1 (en) * | 2012-12-12 | 2014-06-12 | Noam Pik | System and method for assessing health risk for mixed breed animals |
CN104543416A (en) * | 2013-10-09 | 2015-04-29 | 中国科学院大连化学物理研究所 | Functional monosaccharide feed for adjusting reproductive performance of female animals and application thereof |
CN112237156A (en) * | 2020-10-23 | 2021-01-19 | 宁波大学 | Device and experimental method for testing autonomous social behaviors of small animals |
CN112237156B (en) * | 2020-10-23 | 2022-07-22 | 宁波大学 | Autonomous social behavior testing device and experimental method for small animals |
EP4064287A1 (en) | 2021-03-24 | 2022-09-28 | ZuchtData EDV Dienstleistungen GmbH | Method for predicting diseases of farm animals |
Also Published As
Publication number | Publication date |
---|---|
CA2387780A1 (en) | 2001-04-26 |
EP1223852A1 (en) | 2002-07-24 |
CA2387780C (en) | 2011-10-11 |
JP2003523176A (en) | 2003-08-05 |
US6537213B2 (en) | 2003-03-25 |
US7029441B2 (en) | 2006-04-18 |
AU782474B2 (en) | 2005-08-04 |
US20030013942A1 (en) | 2003-01-16 |
US20030139655A1 (en) | 2003-07-24 |
AU7830800A (en) | 2001-04-30 |
EP1223852A4 (en) | 2007-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2387780C (en) | Animal health diagnosis | |
US6287254B1 (en) | Animal health diagnosis | |
US6730023B1 (en) | Animal genetic and health profile database management | |
US7797145B2 (en) | Animal health diagnostics | |
US7865343B2 (en) | Method of analyzing nutrition for a canine or feline animal | |
US20050090718A1 (en) | Animal healthcare well-being and nutrition | |
US8234099B2 (en) | Computer program for determining a nutritional diet product for a canine or feline animal | |
Summers et al. | Prevalence of disorders recorded in Cavalier King Charles Spaniels attending primary-care veterinary practices in England | |
EP2347009A2 (en) | Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type | |
Czubacka et al. | Urinary bisphenol A concentrations and parameters of ovarian reserve among women from a fertility clinic | |
Stróżewska et al. | Mutations in GHR and IGF1R Genes as a potential reason for the lack of catch-up growth in SGA children | |
Nguyen et al. | Anti-Mullerian Hormone-Based Phenotyping Identifies Subgroups of Women with Polycystic Ovary Syndrome with Differing Clinical and Biochemical Characteristics | |
CA2451685A1 (en) | Animal healthcare, well-being and nutrition | |
Simionescu et al. | Missed Down syndrome cases after first trimester false-negative screening—lessons to be learned | |
AU2005202664A1 (en) | Animal Health Diagnosis | |
Almalki et al. | Association between Chronological Age and IGF-1, IGFBP-3, and CTX Levels in Saliva of Children through Younger Adult Population with Varying Periodontal Status | |
AU2002362423A1 (en) | Animal healthcare, well-being and nutrition | |
US20240079086A1 (en) | Execution and communication protocol for algorithmic processing in a diagnostics system | |
PET et al. | 1000 Louisiana, Suite 5100 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2001 531017 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2387780 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 518482 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000968382 Country of ref document: EP Ref document number: 78308/00 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2000968382 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 78308/00 Country of ref document: AU |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |